High-fidelity Cas13 variants for targeted RNA degradation with minimal collateral effect.

2022 Tong, H., Huang, J.*, Xiao,Q., He, B., Dong, X., Liu, Y., Yang, X., Han, D., Wang, Z., Ying, W., Zhang, R., Wei, Y., Wang, X., Xu, C., Zhou, Y., Li, Y., Cai, M., Wang, Q., Xue, M., Li, G., Fang, K., Zhang, H.*, Yang, H.*